DANIE COULOMBE: Open Payments
NPI 1871262634 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 15 payments from 10 companies in 2025. Trend: 2023 $100 · 2024 $24 · 2025 $777
Food & beverage: $579Education: $198
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $213 |
| Daiichi Sankyo Inc. | 2 | $168 |
| Janssen Biotech, Inc. | 2 | $154 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $85 |
| Caris MPI, Inc. | 2 | $34 |
| Geron Corporation | 1 | $28 |
| Tempus AI, Inc | 1 | $27 |
| Genentech USA, Inc. | 1 | $24 |
| TerSera Therapeutics LLC | 1 | $23 |
| Incyte Corporation | 1 | $21 |
Products named: RYBREVANT, DATROWAY, NERLYNX, MI CANCER SEEK, RYTELO, XT CDX, Phesgo, Zoladex.
Industry payments across FL — which companies pay providers there.
